SEC Filing Timeline
8-KJul 07, 2026
Reg FD disclosure · Items 7.01,8.01,9.01
8-KMay 28, 2026
Shareholder vote results · Items 5.07
8-KMay 13, 2026
Earnings release · Items 2.02,9.01
10-QMay 13, 2026
Quarterly report
DEF 14AApr 15, 2026
Proxy statement
10-KMar 24, 2026
Annual report
8-KMar 24, 2026
Earnings release · Items 2.02,9.01
8-KFeb 19, 2026
Material agreement · Items 1.01,7.01,9.01
424B5Feb 19, 2026
Prospectus / offering
424B5Feb 17, 2026
Prospectus / offering
8-KFeb 17, 2026
Reg FD disclosure · Items 7.01,8.01,9.01
Recent News (Finnhub)
AtaiBeckley: 'Hold'; Eli Lilly Acquisition For $2.8 Billion Adds To Its Neuroscience Pipeline
Why Is GH Research Stock Trading Higher on Thursday?
Compass Pathways Announces Publication Of Post-Hoc Analysis Of Support Methods In Phase 2 Study Of Investigational COMP360 Synt…
Why JB Hunt Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Is COMPASS Pathways plc (CMPS) Stock a Psychedelic Medicine Opportunity After Positive COMP360 Data?
The Race to Commercialize the World’s Most Powerful Psychedelic
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Psychedelics guidance from the FDA set to benefit developers, including AtaiBeckley, Jefferies says